£890.00

The 2027-2032 World Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs

Price data checked 2 days ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£890 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 89 days · 89 data points

Historical
Generating forecast…
£890.00 £845.50 £863.30 £881.10 £898.90 £916.70 £934.50 27 April 2026 19 May 2026 10 June 2026 02 July 2026 24 July 2026

Price Distribution

Price distribution over 89 days • 1 price levels

Days at Price
89 days 0 22 45 67 89 £890 Days at Price

Price Analysis

Most common price: £890 (89 days, 100.0%)

Price range: £890 - £890

Price levels: 1 different prices over 89 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
05 January 2026
Listed Since
04 February 2026

Similar Products You Might Like

The 2026-2031 World Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs
99% match

The 2026-2031 World Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs

£885.00 24 Jul 2026
The 2023-2028 World Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs
99% match

The 2023-2028 World Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs

£795.00 23 Jul 2026
The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in Japan
99% match

The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in Japan

£495.00 16 Jun 2026
The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs for US Zip Codes
98% match

The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs for US Zip Codes

£490.00 24 Jun 2026
The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs in Japan
98% match

The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs in Japan

£495.00 17 Jun 2026
The 2027-2032 World Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs
98% match

The 2027-2032 World Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs

£890.00 18 Jul 2026
The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs for US Zip Codes
97% match

The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs for US Zip Codes

£490.00 27 Jun 2026
The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs in the United States
97% match

The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs in the United States

£520.00 10 Jun 2026
The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs in Japan
97% match

The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs in Japan

£495.00 11 Jun 2026
The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs for US Zip Codes
96% match

The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs for US Zip Codes

£490.00 24 Jun 2026
The 2023-2028 Outlook for Anticholinergic Motion Sickness Treatments in China
95% match

The 2023-2028 Outlook for Anticholinergic Motion Sickness Treatments in China

£495.00 17 Jun 2026
The 2023-2028 Outlook for Motion Sickness Medications in the United States
95% match

The 2023-2028 Outlook for Motion Sickness Medications in the United States

£520.00 25 Jun 2026
The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
95% match

The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies

£885.00 13 Jun 2026
The 2023-2028 Outlook for Motion Sickness Medications in India
95% match

The 2023-2028 Outlook for Motion Sickness Medications in India

£515.00 23 Jun 2026
The 2023-2028 Outlook for Anticholinergic Motion Sickness Treatments in Japan
95% match

The 2023-2028 Outlook for Anticholinergic Motion Sickness Treatments in Japan

£495.00 13 Jun 2026
The 2016-2021 Outlook for Motion Sickness Medications in the United States
95% match

The 2016-2021 Outlook for Motion Sickness Medications in the United States

£595.00 19 Jun 2026
The 2023-2028 Outlook for Motion Sickness Treatments in India
95% match

The 2023-2028 Outlook for Motion Sickness Treatments in India

£515.00 25 Jun 2026
The 2023-2028 Outlook for Motion Sickness Treatments in the United States
95% match

The 2023-2028 Outlook for Motion Sickness Treatments in the United States

£520.00 23 Jun 2026
The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
95% match

The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies

£795.00 03 Jul 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India
95% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India

£515.00 18 Jun 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in the United States
95% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in the United States

£520.00 13 Jun 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
95% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States

£520.00 18 Jun 2026
The 2023 Report on Antiemetics: World Market Segmentation by City
95% match

The 2023 Report on Antiemetics: World Market Segmentation by City

£795.00 16 Jun 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in India
95% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in India

£515.00 18 Jun 2026